共 12 条
[1]
Richard H.W., Elusion. AABB, TECHNICAL MANUAL, 10, (1990)
[2]
Hoofnagle J.H., Mullen K.D., Jones D.B., Et al., Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon, N Engl J Med, 315, (1986)
[3]
Thomson B.J., Doran M., Lever A.M.L., Et al., Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gamma-globulin replacement therapy, Lancet, 1, (1987)
[4]
Schattner A., Interferons and autoimmunity, Am J Med Sci, 295, (1988)
[5]
Mayet W.J., Hess G., Gerken G., Et al., Treatment of chronic type B specific for autoimmune chronic hepatitis, Hepatology, 10, (1989)
[6]
Conlon K.C., Urba W.J., Smith J., Et al., Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy, Cancer, 65, (1990)
[7]
Schultz M., Muler R., Von Zur Mulen A., Et al., Induction of hyperthyroidism by interferon a-2b, Lancet, 1, (1989)
[8]
Akard L.P., Hoffman R., Elias L., Et al., Alpha-interferon and immune hemolytic anemia, Ann Intern Med, 105, (1986)
[9]
Fornaciari G., Bassi C., Beltrami M., Et al., Hemolytic anemia secondary to interferon treatment for chronic B hepatitis (letter), J Clin Gastroenterol, 596, (1991)
[10]
Chaplin H., Jr. Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemia, Prog Hematol, 7, (1973)